Obesity and the risk of new-onset atrial fibrillation - PubMed (original) (raw)
Obesity and the risk of new-onset atrial fibrillation
Thomas J Wang et al. JAMA. 2004.
Abstract
Context: Obesity is associated with atrial enlargement and ventricular diastolic dysfunction, both known predictors of atrial fibrillation (AF). However, it is unclear whether obesity is a risk factor for AF.
Objective: To examine the association between body mass index (BMI) and the risk of developing AF.
Design, setting, and participants: Prospective, community-based observational cohort in Framingham, Mass. We studied 5282 participants (mean age, 57 [SD, 13] years; 2898 women [55%]) without baseline AF (electrocardiographic AF or arterial flutter). Body mass index (calculated as weight in kilograms divided by square of height in meters) was evaluated as both a continuous and a categorical variable (normal defined as <25.0; overweight, 25.0 to <30.0; and obese, > or =30.0). In addition to adjusting for clinical confounders by multivariable techniques, we also examined models including echocardiographic left atrial diameter to examine whether the influence of obesity was mediated by changes in left atrial dimensions.
Main outcome measure: Association between BMI or BMI category and risk of developing new-onset AF.
Results: During a mean follow-up of 13.7 years, 526 participants (234 women) developed AF. Age-adjusted incidence rates for AF increased across the 3 BMI categories in men (9.7, 10.7, and 14.3 per 1000 person-years) and women (5.1, 8.6, and 9.9 per 1000 person-years). In multivariable models adjusted for cardiovascular risk factors and interim myocardial infarction or heart failure, a 4% increase in AF risk per 1-unit increase in BMI was observed in men (95% confidence interval [CI], 1%-7%; P = .02) and in women (95% CI, 1%-7%; P = .009). Adjusted hazard ratios for AF associated with obesity were 1.52 (95% CI, 1.09-2.13; P = .02) and 1.46 (95% CI, 1.03-2.07; P = .03) for men and women, respectively, compared with individuals with normal BMI. After adjustment for echocardiographic left atrial diameter in addition to clinical risk factors, BMI was no longer associated with AF risk (adjusted hazard ratios per 1-unit increase in BMI, 1.00 [95% CI, 0.97-1.04], P = .84 in men; 0.99 [95% CI, 0.96-1.02], P = .56 in women).
Conclusions: Obesity is an important, potentially modifiable risk factor for AF. The excess risk of AF associated with obesity appears to be mediated by left atrial dilatation. These prospective data raise the possibility that interventions to promote normal weight may reduce the population burden of AF.
Comment in
- Obesity and atrial fibrillation: is one epidemic feeding the other?
Coromilas J. Coromilas J. JAMA. 2004 Nov 24;292(20):2519-20. doi: 10.1001/jama.292.20.2519. JAMA. 2004. PMID: 15562134 No abstract available. - Obesity and the risk of new-onset atrial fibrillation.
Bajaj HS, Hillson SD. Bajaj HS, et al. JAMA. 2005 Apr 27;293(16):1974-5; author reply 1975. doi: 10.1001/jama.293.16.1974-c. JAMA. 2005. PMID: 15855423 No abstract available. - Obesity and the risk of new-onset atrial fibrillation.
Parish D. Parish D. JAMA. 2005 Apr 27;293(16):1974; author reply 1975. doi: 10.1001/jama.293.16.1974-b. JAMA. 2005. PMID: 15855424 No abstract available. - Obesity and the risk of new-onset atrial fibrillation.
Korantzopoulos P, Kolettis TM. Korantzopoulos P, et al. JAMA. 2005 Apr 27;293(16):1974; author reply 1975. doi: 10.1001/jama.293.16.1974-a. JAMA. 2005. PMID: 15855425 No abstract available.
Similar articles
- Obesity and risk of new-onset atrial fibrillation after cardiac surgery.
Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Zacharias A, et al. Circulation. 2005 Nov 22;112(21):3247-55. doi: 10.1161/CIRCULATIONAHA.105.553743. Epub 2005 Nov 14. Circulation. 2005. PMID: 16286585 - Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population.
Baek YS, Yang PS, Kim TH, Uhm JS, Park J, Pak HN, Lee MH, Joung B. Baek YS, et al. J Am Heart Assoc. 2017 Jun 6;6(6):e004705. doi: 10.1161/JAHA.116.004705. J Am Heart Assoc. 2017. PMID: 28588091 Free PMC article. - Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults.
Berkovitch A, Kivity S, Klempfner R, Segev S, Milwidsky A, Erez A, Sabbag A, Goldenberg I, Sidi Y, Maor E. Berkovitch A, et al. Am Heart J. 2016 Mar;173:41-8. doi: 10.1016/j.ahj.2015.11.016. Epub 2015 Dec 18. Am Heart J. 2016. PMID: 26920595 - Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis.
Asad Z, Abbas M, Javed I, Korantzopoulos P, Stavrakis S. Asad Z, et al. J Cardiovasc Electrophysiol. 2018 May;29(5):725-732. doi: 10.1111/jce.13458. Epub 2018 Feb 27. J Cardiovasc Electrophysiol. 2018. PMID: 29443438 Review. - Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies.
Guijian L, Jinchuan Y, Rongzeng D, Jun Q, Jun W, Wenqing Z. Guijian L, et al. Pacing Clin Electrophysiol. 2013 Jun;36(6):748-56. doi: 10.1111/pace.12106. Epub 2013 Feb 25. Pacing Clin Electrophysiol. 2013. PMID: 23437987
Cited by
- Pregnancy-driven cardiovascular maternal miR-29 plasticity in obesity.
Schlabritz-Loutsevitch N, Apostolakis-Kyrus K, Krutilina R, Hubbard G, Kocak M, Janjetovic Z, Sathanandam S, Slominski AT, Mari G, Dick E Jr. Schlabritz-Loutsevitch N, et al. J Med Primatol. 2016 Dec;45(6):297-303. doi: 10.1111/jmp.12236. Epub 2016 Sep 15. J Med Primatol. 2016. PMID: 27627870 Free PMC article. - Atrial Myopathy Underlying Atrial Fibrillation.
Rivner H, Mitrani RD, Goldberger JJ. Rivner H, et al. Arrhythm Electrophysiol Rev. 2020 Aug;9(2):61-70. doi: 10.15420/aer.2020.13. Arrhythm Electrophysiol Rev. 2020. PMID: 32983526 Free PMC article. Review. - Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway.
Feng D, Xu D, Murakoshi N, Tajiri K, Qin R, Yonebayashi S, Okabe Y, Li S, Yuan Z, Aonuma K, Ieda M. Feng D, et al. Int J Mol Sci. 2020 Jun 30;21(13):4655. doi: 10.3390/ijms21134655. Int J Mol Sci. 2020. PMID: 32629939 Free PMC article. - Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis.
Karakasis P, Ktenopoulos N, Pamporis K, Sagris M, Soulaidopoulos S, Gerogianni M, Leontsinis I, Giannakoulas G, Tousoulis D, Fragakis N, Tsioufis K. Karakasis P, et al. J Clin Med. 2024 Jun 27;13(13):3784. doi: 10.3390/jcm13133784. J Clin Med. 2024. PMID: 38999350 Free PMC article. Review. - Obesity Cardiomyopathy in Sudden Cardiac Death: A Distinct Entity? A Comparative Study.
Westaby J, Dalle-Carbonare C, Ster IC, Sheppard MN. Westaby J, et al. JACC Adv. 2023 Jul 28;2(5):100414. doi: 10.1016/j.jacadv.2023.100414. eCollection 2023 Jul. JACC Adv. 2023. PMID: 38938994 Free PMC article.
Publication types
MeSH terms
Grants and funding
- 6R01-NS-17950/NS/NINDS NIH HHS/United States
- K23-HL074077-01/HL/NHLBI NIH HHS/United States
- K24-HL-04334/HL/NHLBI NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical